FibroGen Inc (NASDAQ:FGEN)’s traded shares stood at 1.03 million during the last session, with the company’s beta value hitting 0.85. At the close of trading,
FibroGen Inc (NASDAQ:FGEN) has a beta value of 0.77 and has seen 1.01 million shares traded in the last trading session. The company, currently valued
During the last session, FibroGen Inc (NASDAQ:FGEN)’s traded shares were 1.62 million, with the beta value of the company hitting 0.79. At the end of
FibroGen Inc (NASDAQ:FGEN)’s traded shares stood at 1.35 million during the last session, with the company’s beta value hitting 0.72. At the close of trading,
In the last trading session, 1.54 million FibroGen Inc (NASDAQ:FGEN) shares changed hands as the company’s beta touched 0.71. With the company’s per share price
In last trading session, FibroGen Inc (NASDAQ:FGEN) saw 1.55 million shares changing hands with its beta currently measuring 0.71. Company’s recent per share price level
FibroGen Inc (NASDAQ:FGEN) has a beta value of 0.66 and has seen 1.27 million shares traded in the last trading session. The company, currently valued
During the last session, FibroGen Inc (NASDAQ:FGEN)’s traded shares were 2.06 million, with the beta value of the company hitting 0.66. The 52-week high for
In the last trading session, 2.05 million shares of the FibroGen Inc (NASDAQ:FGEN) were traded, and its beta was 0.66. Most recently the company’s share
FibroGen Inc (NASDAQ:FGEN)’s traded shares stood at 1.13 million during the last session, with the company’s beta value hitting 0.66. At the close of trading,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
